Integration of AI in Medical Communications: A Roadmap
AI in medical communications: Why it matters now Artificial intelligence (AI) is rapidly reshaping medical communications (MedComms), driven by the necessity for personalization, efficiency, and speed in content delivery. As pharmaceutical companies face mounting competition, the demand for innovative communication strategies to communicate complex data and information, as early as the critical pre-launch phase, is…...
Read MoreTop Stories
The Nelson Memo: Igniting a Global Open Data
The landscape of scientific research is undergoing a seismic...
Rare Diseases – An Evolving Medical
A disease is considered rare when it affects fewer than 1 in...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches
At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered...
It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with...
Periodic Safety Update Report (PSUR): A Breakdown of MDCG 2022-21
A well-structured, clear, and concise PSUR enables a seamless notified body review. Read our key...
Launch Excellence: The Path Forward for Medical Affairs
Learn how Medical Affairs can redefine launch excellence by streamlining the journey from clinical trial...
Diversity, Equity, and Inclusion: The Fuel That Drives Business Forward
Ensuring that your organization embraces DE & I training is important for cultivating a strong...
Clinical Evidence: How Much Is Enough?
Ensuring the safety and functionality of your medical device is vital. But how much clinical...
- 1
- 2